1. Quintanilla-Martinez L, Ko YH, Kimura H, Jaffe ES. EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Geneva: WHO Press; 2017. p. 355–63.
2. Cohen JI, Iwatsuki K, Ko YH, Kimura H, Manoli I, Ohshima K, et al. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting. Leuk Lymphoma. 2020;61:808–19.
3. Quintanilla-Martinez L, Koh YH, Iwatsuki K. 2018 Cutaneous manifestations of chronic active EBV infection. In: WHO classification skin tumours. IARC. p.244–6.
4. Japanese Society for Pediatric Infectious DiseaseGuidelines for the management of chronic active EBV disease and related disorders. Tokyo: SHINDAN TO CHIRYO SHA; 2023;Inc. 2023. p.15–7.
5. Iwatsuki K, Miyake T, Hirai Y, Yamamoto T. Hydroa vacciniforme: A distinctive form of Epstein-Barr virus-associated T-cell lymphoproliferative disorders. Eur J Dermatol. 2019;29:21–8.